Sight Sciences (SGHT) Gains from Investment Securities (2020 - 2026)
Sight Sciences (SGHT) recorded quarterly Gains from Investment Securities of -$102000.0 in Q1 2026, up 73.78% quarter-over-quarter from -$389000.0 in Q4 2025, and down 218.75% on a YoY basis from $85894.7 in Q1 2025.
Sight Sciences (SGHT) Gains from Investment Securities (2020 - 2026) Analysis & Trends
Sight Sciences' Gains from Investment Securities history runs 7 years deep, the most recent figure standing at -$102000.0 for Q1 2026.
- In Q1 2026, Gains from Investment Securities fell 218.75% year-over-year to -$102000.0; the TTM figure through Mar 2026 stood at -$423000.0 (down 244.37% YoY), while the FY2025 annual figure was $3.1 million, down 31.38% from the prior year.
- Gains from Investment Securities was -$102000.0 for Q1 2026 at Sight Sciences, up from -$389000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $3.7 million in Q3 2025 to a low of -$389000.0 in Q4 2025.
- Historically, Gains from Investment Securities has averaged $419552.3 across 5 years, with a median of $100000.0 in 2023.
- The sharpest annual moves came in 2023 and 2025: Gains from Investment Securities jumped 5260.0% in 2023, then sank 1656.0% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at $10000.0 in 2022, then surged by 5260.0% to $536000.0 in 2023, then plunged by 95.34% to $25000.0 in 2024, then tumbled by 1656.0% to -$389000.0 in 2025, then jumped by 73.78% to -$102000.0 in 2026.
- The last three Gains from Investment Securities figures came in at -$102000.0 (Q1 2026), -$389000.0 (Q4 2025), and $3.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Sight Sciences | 284.28 Mn | 199.32 Mn | 16.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -102,000.00 |
| Mar 31, 2026 | -102,000.00 |
| Dec 31, 2025 | -389,000.00 |
| Dec 31, 2025 | -389,000.00 |
| Sep 30, 2025 | 3.69 Mn |
| Sep 30, 2025 | 3.69 Mn |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | -32,000.00 |
| Mar 31, 2025 | -32,000.00 |
| Dec 31, 2024 | 25,000.00 |
| Dec 31, 2024 | 25,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 7,377.00 |
| Mar 31, 2024 | 7,377.00 |
| Dec 31, 2023 | 536,000.00 |
| Dec 31, 2023 | 536,000.00 |